Trial Outcomes & Findings for Measures to Lower the Stress Response in Pediatric Cardiac Surgery (NCT NCT00848393)

NCT ID: NCT00848393

Last Updated: 2018-07-27

Results Overview

N = 48 n = 16 (LDF); n = 17 (HDF); n = 15 (LDF + Dex) ACTH assayed by enzyme-linked immunosorbent assay (ELISA); Cytokine levels in plasma were measured using the Immulite automated chemiluminometer. Measured cytokines include interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor-α.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

52 participants

Primary outcome timeframe

Blood draws to measure cytokines levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.

Results posted on

2018-07-27

Participant Flow

A total of 51 study subjects completed the study.

Total number of subjects recruited was 52 patients (one enrollee withdrew prior to any study-related procedures) resulting in a total number of subjects participating of 51. The enrollee was withdrawn from the study after signing the consent and prior to enrolling to one of the arms of the study.

Participant milestones

Participant milestones
Measure
Fentanyl (High Dose)
Patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Fentanyl (Low Dose)
Patients in this arm will receive a total of 10 mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10 mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
Patients in this arm will receive a total of 10 mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1 mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1 mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5 mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Overall Study
STARTED
17
16
18
Overall Study
COMPLETED
17
16
15
Overall Study
NOT COMPLETED
0
0
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Fentanyl (High Dose)
Patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Fentanyl (Low Dose)
Patients in this arm will receive a total of 10 mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10 mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
Patients in this arm will receive a total of 10 mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1 mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1 mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5 mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Overall Study
Protocol Violation
0
0
1
Overall Study
surgical complications unrelated to stud
0
0
2

Baseline Characteristics

Measures to Lower the Stress Response in Pediatric Cardiac Surgery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Fentanyl (High Dose)
n=17 Participants
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Fentanyl (Low Dose)
n=16 Participants
patients in this group will receive a total of 10mcg/kg of fentanyl. half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of fentanyl. half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=15 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Total
n=48 Participants
Total of all reporting groups
Age, Categorical
<=18 years
17 Participants
n=5 Participants
16 Participants
n=7 Participants
15 Participants
n=5 Participants
48 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Continuous
4 months
n=5 Participants
4 months
n=7 Participants
5 months
n=5 Participants
4 months
n=4 Participants
Sex: Female, Male
Female
8 Participants
n=5 Participants
4 Participants
n=7 Participants
4 Participants
n=5 Participants
16 Participants
n=4 Participants
Sex: Female, Male
Male
9 Participants
n=5 Participants
12 Participants
n=7 Participants
11 Participants
n=5 Participants
32 Participants
n=4 Participants
Region of Enrollment
United States
17 participants
n=5 Participants
16 participants
n=7 Participants
15 participants
n=5 Participants
48 participants
n=4 Participants

PRIMARY outcome

Timeframe: Blood draws to measure cytokines levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.

N = 48 n = 16 (LDF); n = 17 (HDF); n = 15 (LDF + Dex) ACTH assayed by enzyme-linked immunosorbent assay (ELISA); Cytokine levels in plasma were measured using the Immulite automated chemiluminometer. Measured cytokines include interleukin (IL)-6, IL-8, IL-10, and tumor necrosis factor-α.

Outcome measures

Outcome measures
Measure
Fentanyl (Low Dose)
n=16 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=15 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Fentanyl (High Dose)
n=17 Participants
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
ACTH and Cytokine Levels
Post-Bypass ACTH (pg/mL)
172.7 pg/mL
Standard Deviation 121.8
191.6 pg/mL
Standard Deviation 220.2
57.2 pg/mL
Standard Deviation 61.2
ACTH and Cytokine Levels
24 hour Post-Surgery IL-10 (pg/mL)
14.80833 pg/mL
Standard Deviation 10.65888
9.692857 pg/mL
Standard Deviation 0.775058
10.80667 pg/mL
Standard Deviation 1.907304
ACTH and Cytokine Levels
Baseline ACTH (pg/mL)
182.7 pg/mL
Standard Deviation 111.3
135.3 pg/mL
Standard Deviation 129.8
116.9 pg/mL
Standard Deviation 117.0
ACTH and Cytokine Levels
Post-Sternotomy ACTH (pg/mL)
86.2 pg/mL
Standard Deviation 76.5
106.9 pg/mL
Standard Deviation 153.5
44.5 pg/mL
Standard Deviation 39.7
ACTH and Cytokine Levels
End-Of-Surgery ACTH (pg/mL)
155.0 pg/mL
Standard Deviation 107.5
154.1 pg/mL
Standard Deviation 166.6
66.4 pg/mL
Standard Deviation 77.9
ACTH and Cytokine Levels
24 hour Post-Surgery ACTH (pg/mL)
53.2 pg/mL
Standard Deviation 24.3
22.4 pg/mL
Standard Deviation 130.3
12.7 pg/mL
Standard Deviation 7.4
ACTH and Cytokine Levels
Baseline TNF-alpha (pg/mL)
25.294 pg/mL
Standard Deviation 31.22396
8.018182 pg/mL
Standard Deviation 10.68364
15.70077 pg/mL
Standard Deviation 16.401
ACTH and Cytokine Levels
Post-Sternotomy TNF-alpha (pg/mL)
24.497 pg/mL
Standard Deviation 33.8474
17.88636 pg/mL
Standard Deviation 16.96651
26.51846 pg/mL
Standard Deviation 33.64902
ACTH and Cytokine Levels
Post-Bypass TNF-alpha (pg/mL)
25.787 pg/mL
Standard Deviation 29.267
20.34364 pg/mL
Standard Deviation 14.03041
24.30615 pg/mL
Standard Deviation 23.03753
ACTH and Cytokine Levels
End-Of-Surgery TNF-alpha (pg/mL)
24.857 pg/mL
Standard Deviation 18.82328
23.06091 pg/mL
Standard Deviation 18.8737
23.87077 pg/mL
Standard Deviation 17.18903
ACTH and Cytokine Levels
24 hour Post-Surgery TNF-alpha (pg/mL)
11.954 pg/mL
Standard Deviation 17.23623
21.13909 pg/mL
Standard Deviation 19.00043
15.79 pg/mL
Standard Deviation 30.8563
ACTH and Cytokine Levels
Baseline IL-6 (pg/mL)
4.757142857 pg/mL
Standard Deviation 2.178819118
5.542857143 pg/mL
Standard Deviation 3.455366904
6.637058824 pg/mL
Standard Deviation 4.356124661
ACTH and Cytokine Levels
Post-Sternotomy IL-6 (pg/mL)
12.17333 pg/mL
Standard Deviation 28.79942
6.241333 pg/mL
Standard Deviation 4.0798
5.402353 pg/mL
Standard Deviation 3.623996
ACTH and Cytokine Levels
Post-Bypass IL-6 (pg/mL)
5.509375 pg/mL
Standard Deviation 3.93354
5.040667 pg/mL
Standard Deviation 2.583747
5.098824 pg/mL
Standard Deviation 3.10355
ACTH and Cytokine Levels
End-Of-Surgery IL-6 (pg/mL)
22.47333 pg/mL
Standard Deviation 12.59657
20.79231 pg/mL
Standard Deviation 12.55537
20.48571 pg/mL
Standard Deviation 11.00962
ACTH and Cytokine Levels
24 hour Post-Surgery IL-6 (pg/mL)
117.975 pg/mL
Standard Deviation 95.86805
142.1571 pg/mL
Standard Deviation 129.4279
126.0813 pg/mL
Standard Deviation 141.7456
ACTH and Cytokine Levels
Baseline IL-8 (pg/mL)
10.44286 pg/mL
Standard Deviation 1.839195
10.25714 pg/mL
Standard Deviation 1.336306
17.12353 pg/mL
Standard Deviation 24.88048
ACTH and Cytokine Levels
Post-Sternotomy IL-8 (pg/mL)
10.66667 pg/mL
Standard Deviation 2.941736
10.86667 pg/mL
Standard Deviation 1.980861
20.77647 pg/mL
Standard Deviation 42.23163
ACTH and Cytokine Levels
Post-Bypass IL-8 (pg/mL)
10.13125 pg/mL
Standard Deviation 2.15769
9.673333 pg/mL
Standard Deviation 1.182894
9.770588 pg/mL
Standard Deviation 2.389499
ACTH and Cytokine Levels
End-Of-Surgery IL-8 (pg/mL)
33.12667 pg/mL
Standard Deviation 25.1446
37.22143 pg/mL
Standard Deviation 43.66227
28.1 pg/mL
Standard Deviation 17.28596
ACTH and Cytokine Levels
24 hour Post-Surgery IL-8 (pg/mL)
47.25 pg/mL
Standard Deviation 99.4908
24.27143 pg/mL
Standard Deviation 14.72541
49.07143 pg/mL
Standard Deviation 69.39429
ACTH and Cytokine Levels
Baseline IL-10 (pg/mL)
9.9 pg/mL
Standard Deviation 0.00000
12.76429 pg/mL
Standard Deviation 9.373252
10.82353 pg/mL
Standard Deviation 1.952412
ACTH and Cytokine Levels
Post-Sternotomy IL-10 (pg/mL)
9.9 pg/mL
Standard Deviation 0.00000
14.10667 pg/mL
Standard Deviation 13.63863
9.911765 pg/mL
Standard Deviation 2.749291
ACTH and Cytokine Levels
Post-Bypass IL-10 (pg/mL)
9.9 pg/mL
Standard Deviation 2.581989
12.30667 pg/mL
Standard Deviation 10.78136
9.488235 pg/mL
Standard Deviation 1.872793
ACTH and Cytokine Levels
End-Of-Surgery IL-10 (pg/mL)
325.55 pg/mL
Standard Deviation 262.3603
569.2714 pg/mL
Standard Deviation 858.2538
345.4412 pg/mL
Standard Deviation 445.7443

PRIMARY outcome

Timeframe: Hospital admission to discharge from CTICU (average of 2-4 days)

Outcome measures

Outcome measures
Measure
Fentanyl (Low Dose)
n=16 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=15 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Fentanyl (High Dose)
n=17 Participants
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Comparisons Between Groups for Narcotic and/or Dexmedetomidine Intervention Influence on Length of CTICU Stay.
1 Days
Interval 1.0 to 4.0
2 Days
Interval 1.0 to 5.0
1 Days
Interval 1.0 to 8.0

PRIMARY outcome

Timeframe: Time of intubation to extubation (variable)

Outcome measures

Outcome measures
Measure
Fentanyl (Low Dose)
n=16 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=15 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Fentanyl (High Dose)
n=17 Participants
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Comparisons Between Groups for Narcotic and/or Dexmedetomidine Intervention Influence on Time on Ventilator.
3.79 Hours
Interval 0.0 to 16.0
2.4 Hours
Interval 0.0 to 2.4
10.75 Hours
Interval 0.0 to 27.32

PRIMARY outcome

Timeframe: 1-4 yrs. post-surgery

Population: Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.

The Stanford-Binet test evaluates the overall IQ score from the assessment of cognitive ability. The test consists of 15 subtests, grouped into the four area scores. Six subtests are administered to all age levels. The subtests are: Vocabulary, Comprehension, Pattern Analysis, Quantitative, Bead Memory, and Memory for Sentences. Number of tests administered and test difficulty are based on the test taker's age and performance on subtest measuring word knowledge. The word knowledge subtest is given to all test takers and is the first subtest administered. A score of 100 is in the normal or average range. Higher scores suggest a higher level of functioning related to each category. (University of Cincinnati, 2003) Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150).

Outcome measures

Outcome measures
Measure
Fentanyl (Low Dose)
n=9 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=7 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Fentanyl (High Dose)
n=5 Participants
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Stanford-Binet Intelligence Scales
Nonverbal IQ composite score
98 IQ
Standard Deviation 15
89 IQ
Standard Deviation 6
92 IQ
Standard Deviation 19
Stanford-Binet Intelligence Scales
Verbal IQ composite score
91 IQ
Standard Deviation 17
80 IQ
Standard Deviation 8
93 IQ
Standard Deviation 26
Stanford-Binet Intelligence Scales
Full-scale IQ composite score
94 IQ
Standard Deviation 15
83 IQ
Standard Deviation 5
93 IQ
Standard Deviation 24

PRIMARY outcome

Timeframe: Blood draws to measure stress hormone levels within one hour of draw: after induction; after sternotomy; after starting cardiopulmonary bypass; at the end of the procedure; and 24 hours after the procedure.

Cortisol, epinephrine, and norepinephrine assayed by enzyme-linked immunosorbent assay (ELISA).

Outcome measures

Outcome measures
Measure
Fentanyl (Low Dose)
n=16 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=15 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Fentanyl (High Dose)
n=17 Participants
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Stress Hormone Levels
Baseline Norepinephrine
19.34153 ng/mL
Standard Deviation 9.880667
19.45968 ng/mL
Standard Deviation 13.08422
13.32618 ng/mL
Standard Deviation 10.1541
Stress Hormone Levels
Post-Sternotomy Norepinephrine
17.08766 ng/mL
Standard Deviation 8.419782
12.74458 ng/mL
Standard Deviation 11.4669
16.2606 ng/mL
Standard Deviation 9.929948
Stress Hormone Levels
Post-Bypass Norepinephrine
22.31064 ng/mL
Standard Deviation 17.06955
19.73612 ng/mL
Standard Deviation 17.07041
23.35796 ng/mL
Standard Deviation 13.54953
Stress Hormone Levels
End-of-Surgery Norepinephrine
10.74731 ng/mL
Standard Deviation 8.144776
7.727055 ng/mL
Standard Deviation 13.04373
11.22376 ng/mL
Standard Deviation 8.599634
Stress Hormone Levels
24 hour Post-Surgery Norepinephrine
20.85433 ng/mL
Standard Deviation 18.38192
26.67379 ng/mL
Standard Deviation 26.06332
19.03031 ng/mL
Standard Deviation 17.41692
Stress Hormone Levels
Baseline ephinephrine
6.439221 ng/mL
Standard Deviation 7.528216
5.876335 ng/mL
Standard Deviation 9.551871
2.7848 ng/mL
Standard Deviation 3.127335
Stress Hormone Levels
Post-Sternotomy Epinephrine
9.843591 ng/mL
Standard Deviation 8.670264
10.89824 ng/mL
Standard Deviation 16.85818
2.376012 ng/mL
Standard Deviation 2.273879
Stress Hormone Levels
Post-Bypass Epinephrine
21.9075 ng/mL
Standard Deviation 15.02187
20.5294 ng/mL
Standard Deviation 17.2838
18.176 ng/mL
Standard Deviation 22.04968
Stress Hormone Levels
End-of-Surgery Epinephrine
8.620669 ng/mL
Standard Deviation 6.799042
8.083004 ng/mL
Standard Deviation 8.808354
14.65742 ng/mL
Standard Deviation 18.34983
Stress Hormone Levels
24 hour Post-Surgery Epinephrine
3.537063 ng/mL
Standard Deviation 2.466451
4.418208 ng/mL
Standard Deviation 6.764226
5.004787 ng/mL
Standard Deviation 6.666509
Stress Hormone Levels
Baseline Cortisol
449.1974 ng/mL
Standard Deviation 279.4671
352.4913 ng/mL
Standard Deviation 265.2216
334.7762 ng/mL
Standard Deviation 314.6592
Stress Hormone Levels
Post-Sternotomy Cortisol
363.5948 ng/mL
Standard Deviation 164.9006
361.0074 ng/mL
Standard Deviation 223.3172
353.5396 ng/mL
Standard Deviation 281.4853
Stress Hormone Levels
Post-Bypass Cortisol
395.1298 ng/mL
Standard Deviation 173.3926
354.8089 ng/mL
Standard Deviation 210.7565
279.0063 ng/mL
Standard Deviation 188.1155
Stress Hormone Levels
End-of-Surgery Cortisol
463.3857 ng/mL
Standard Deviation 251.6977
387.3673 ng/mL
Standard Deviation 191.7376
333.0644 ng/mL
Standard Deviation 294.8148
Stress Hormone Levels
24 hour Post-Surgery Cortisol
266.8754 ng/mL
Standard Deviation 239.2913
265.7373 ng/mL
Standard Deviation 291.3256
237.5506 ng/mL
Standard Deviation 243.8181

SECONDARY outcome

Timeframe: 1-4 yrs post-surgery

Population: Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.

The Stanford-Binet Intelligence Scale is now in its fifth edition (SB5) and was released in 2003. It is a cognitive ability and intelligence test that is used to diagnose developmental or intellectual deficiencies in young children. The test measures five weighted factors and consists of both verbal and nonverbal subtests. The five factors being tested are knowledge, quantitative reasoning, visual-spatial processing, working memory, and fluid reasoning. Raw scores for each subtest within the overall test are converted to scaled scores using a table within each test manual to look up equivalents. Scaled scores are then converted to standard scores (range=50-150). Higher scores suggest a higher level of functioning related to each category.

Outcome measures

Outcome measures
Measure
Fentanyl (Low Dose)
n=9 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=7 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Fentanyl (High Dose)
n=5 Participants
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Stanford-Binet Cognitive Ability
Quantative Reasoning Score
96 units on a scale
Standard Deviation 18
82 units on a scale
Standard Deviation 15
106 units on a scale
Standard Deviation 22
Stanford-Binet Cognitive Ability
Knowledge Score
97 units on a scale
Standard Deviation 10
95 units on a scale
Standard Deviation 12
91 units on a scale
Standard Deviation 27
Stanford-Binet Cognitive Ability
Visual Spatial Processing Score
97 units on a scale
Standard Deviation 16
92 units on a scale
Standard Deviation 7
91 units on a scale
Standard Deviation 17
Stanford-Binet Cognitive Ability
Working Memory Score
92 units on a scale
Standard Deviation 10
84 units on a scale
Standard Deviation 13
94 units on a scale
Standard Deviation 17
Stanford-Binet Cognitive Ability
Fluid Reasoning Score
93 units on a scale
Standard Deviation 19
75 units on a scale
Standard Deviation 10
86 units on a scale
Standard Deviation 20

SECONDARY outcome

Timeframe: 1-4 yrs post-surgery

Population: Six patients underwent their surgical repair after 1 y of age and were excluded from the follow-up neurodevelopmental testing post-surgery. 2 patients were deceased, 11 families refused to participate, 8 patients could not be reached due to relocation to other states or outside the country leaving a total of 21 patients.

The ABAS-II is designed to evaluate whether an individual displays various functional skills necessary for daily living without the assistance of others. Thus, this instrument focuses on independent behaviors and measures what an individual actually does, in addition to measuring what he or she may be able to do. In addition, the ABAS-II focuses on behaviors an individual displays on his or her own, without assistance from others. The Parent/Primary Caregiver Form is a comprehensive, diagnostic measure of the adaptive skills that have primary relevance for the functioning of infants, toddlers, and preschoolers in the home and other settings, and can be completed by parents or other primary care providers. Each composite or domain score is determined by summing the appropriate scaled scores and then determining its equivalent composite or domain score by looking it up in a table located in the manual.The range for all scores is 50-150, with a higher score equaling a better outcome.

Outcome measures

Outcome measures
Measure
Fentanyl (Low Dose)
n=9 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=7 Participants
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose) in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr. In addition, this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Fentanyl (High Dose)
n=5 Participants
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
ABAS-II
ABAS-II Conceptual Adaptive Domain Score
106 units on a scale
Standard Deviation 16
99 units on a scale
Standard Deviation 13
99 units on a scale
Standard Deviation 21
ABAS-II
ABAS-II Social Adaptive Domain Score
106 units on a scale
Standard Deviation 8
105 units on a scale
Standard Deviation 13
102 units on a scale
Standard Deviation 24
ABAS-II
ABAS-II Practical Adaptive Domain Score
96 units on a scale
Standard Deviation 14
95 units on a scale
Standard Deviation 11
93 units on a scale
Standard Deviation 15
ABAS-II
ABAS-II General Adaptive Composite Score
102 units on a scale
Standard Deviation 13
100 units on a scale
Standard Deviation 13
96 units on a scale
Standard Deviation 21

Adverse Events

Fentanyl (High Dose)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Fentanyl (Low Dose)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Fentanyl (Low Dose) + Dexmedetomidine

Serious events: 2 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Fentanyl (High Dose)
n=17 participants at risk
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Fentanyl (Low Dose)
n=16 participants at risk
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=18 participants at risk
patients in this group will receive a total of 10mcg/kg of fentanyl in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr.in addition this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Surgical and medical procedures
Morbidity
0.00%
0/17 • Adverse event data were collected for each patient from start of surgical procedure until hospital discharge (Length of Hospital Stay averaging 5 Days).
0.00%
0/16 • Adverse event data were collected for each patient from start of surgical procedure until hospital discharge (Length of Hospital Stay averaging 5 Days).
11.1%
2/18 • Number of events 2 • Adverse event data were collected for each patient from start of surgical procedure until hospital discharge (Length of Hospital Stay averaging 5 Days).

Other adverse events

Other adverse events
Measure
Fentanyl (High Dose)
n=17 participants at risk
patients in this arm will receive a total of 25 mcg/kg of Fentanyl (High Dose) in two divided doses. first half will be given at induction and the second half will be given before incision. Fentanyl (High Dose): 25 mcg/kg in two divided doses. half the dose will be given at induction and the second half will be given prior to incision.
Fentanyl (Low Dose)
n=16 participants at risk
patients in this group will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half will be given before incision Fentanyl (Low Dose): patients will receive a total of 10mcg/kg of Fentanyl (Low Dose). half the dose will be given at induction and the second half before incision.
Fentanyl (Low Dose) + Dexmedetomidine
n=18 participants at risk
patients in this group will receive a total of 10mcg/kg of fentanyl in two divided doses and Dexmedetomidine at a loading dose of 1mcg/kg over 10 minutes and then an infusion of Dexmedetomidine at 0.5mcg/kg/hr. Fentanyl (Low Dose) + Dexmedetomidine: Dexmedetomidine at 1mcg/kg loading dose over 10 minutes, followed by an infusion at a rate of 0.5mcg/kg/hr.in addition this group will receive a total of 10 mcg/kg Fentanyl (Low Dose). Half the dose will be given at induction and the second half before incision.
Surgical and medical procedures
Unblinded
0.00%
0/17 • Adverse event data were collected for each patient from start of surgical procedure until hospital discharge (Length of Hospital Stay averaging 5 Days).
0.00%
0/16 • Adverse event data were collected for each patient from start of surgical procedure until hospital discharge (Length of Hospital Stay averaging 5 Days).
5.6%
1/18 • Number of events 1 • Adverse event data were collected for each patient from start of surgical procedure until hospital discharge (Length of Hospital Stay averaging 5 Days).

Additional Information

Aymen Naguib, MD

Nationwide Children's Hospital

Phone: 6147220596

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place